The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo

Molecular Cancer Research

Volumn 10, Issue 2, 2012, Pages 250-258

  Bonilla Delgado, José ^a,e   Bulut, Gülay ^b   Liu, Xuefeng ^b   Corteś Malagoń, Enoc M ^a   Schlegel, Richard ^b   Flores Maldonado, Catalina ^a   Contreras, Rubeń G ^a   Chung, Sang Hyuk ^d   Lambert, Paul F ^c   Ur̈en, Aykut ^b   Gariglio, Patricio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d University of Houston   (United States)

^e HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; PROTEIN E6; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EPIDERMIS; EPIDERMIS HYPERPLASIA; GENE EXPRESSION; GENE LOCUS; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MOUSE; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; WNT SIGNALING PATHWAY;

ANIMALS; AXIN PROTEIN; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; EPIDERMIS; GENE EXPRESSION REGULATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; LAC OPERON; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PDZ DOMAINS; PROTEIN BINDING; REPRESSOR PROTEINS; SKIN; WNT SIGNALING PATHWAY;

EID: 84863129986     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0287     Document Type: Article

References (40)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
3. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 2007;98:1505-11. (Pubitemid 47308443)
4. McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology 2009;384:335-44.
5. Tungteakkhun SS, Duerksen-Hughes PJ. Cellular binding partners of the human papillomavirus E6 protein. Arch Virol 2008;153:397-408.
6. Wazer DE, Liu XL, Chu Q, Gao Q, Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A 1995;92:3687-91.
7. Song S, Pitot HC, Lambert PF. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 1999;73:5887-93. (Pubitemid 29274875)
8. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol 2003;77:6957-64. (Pubitemid 36666888)
9. Lichtig H, Gilboa DA, Jackman A, Gonen P, Levav-Cohen Y, Haupt Y, et al. HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology 2010;396:47-58.
10. Goodwin AM, D'Amore PA. Wnt signaling in the vasculature. Angiogenesis 2002;5:1-9. (Pubitemid 36076918)
11. Millar SE, Willert K, Salinas PC, Roelink H, Nusse R, Sussman DJ, et al. WNT signaling in the control of hair growth and structure. Dev Biol 1999;207:133-49. (Pubitemid 29117806)
12. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
13. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999;96:1603-8. (Pubitemid 29098498)
14. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12. (Pubitemid 28425575)
15. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6. (Pubitemid 29180374)
16. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 2000;60:4761-6.
17. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999;18:2883-91. (Pubitemid 29250878)
18. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 2001;98:14973-8. (Pubitemid 34013954)
19. Shinohara A, Yokoyama Y, Wan X, Takahashi Y, Mori Y, Takami T, et al. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol 2001;82:450-5. (Pubitemid 32826443)
20. Imura J, Ichikawa K, Takeda J, Fujimori T. Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med 2001;8:353-8.
21. Pereira-Suarez AL, Meraz MA, Lizano M, Estrada-Chavez C, Hernandez F, Olivera P, et al. Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. Tumour Biol 2002;23:45-53. (Pubitemid 34225021)
22. Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, et al. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 2005;65:6199-206. (Pubitemid 40994405)
23. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002;22:1184-93. (Pubitemid 34094854)
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-8. (Pubitemid 34164012)
25. Nagafuchi A. Molecular architecture of adherens junctions. Curr Opin Cell Biol 2001;13:600-3. (Pubitemid 32817019)
26. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002;22:1172-83. (Pubitemid 34094853)
27. Soshnikova N, Zechner D, Huelsken J, Mishina Y, Behringer RR, Taketo MM, et al. Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsalventral axis in the limb. Genes Dev 2003;17:1963-8. (Pubitemid 36999323)
28. Sakanaka C, Sun TQ, Williams LT. New steps in the Wnt/beta-catenin signal transduction pathway. Recent Prog Horm Res 2000;55:225-36. (Pubitemid 32094451)
29. Wong HC, Bourdelas A, Krauss A, Lee HJ, Shao Y, Wu D, et al. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell 2003;12:1251-60. (Pubitemid 37487932)
30. Charpentier E, Lavker RM, Acquista E, Cowin P. Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol 2000;149:503-20.
31. Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 2000;267:141-50. (Pubitemid 30123597)
32. Elson DA, Riley RR, Lacey A, Thordarson G, Talamantes FJ, Arbeit JM. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 2000;60:1267-75. (Pubitemid 30151994)
33. Mendoza-Villanueva D, Diaz-Chavez J, Uribe-Figueroa L, Rangel-Escareao C, Hidalgo-Miranda A, March-Mifsut S, et al. Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice. BMC Cancer 2008;8:347.
34. Simonson SJ, Difilippantonio MJ, Lambert PF. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res 2005;65:8266-73. (Pubitemid 41330591)
35. Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P, et al. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res 2010;8:433-43.
36. Nguyen MM, Rivera C, Griep AE. Localization of PDZ domain containing proteins Discs Large-1 and Scribble in the mouse eye. Mol Vis 2005;11:1183-99. (Pubitemid 43020118)
37. Matsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, et al. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 1996;272:1020-3. (Pubitemid 26259321)
38. Takizawa S, Nagasaka K, Nakagawa S, Yano T, Nakagawa K, Yasugi T, et al. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. Genes Cells 2006;11:453-64.
39. Ishidate T, Matsumine A, Toyoshima K, Akiyama T. The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene 2000;19:365-72. (Pubitemid 30077336)
40. Cavatorta AL, Fumero G, Chouhy D, Aguirre R, Nocito AL, Giri AA, et al. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy. Int J Cancer 2004;111:373-80. (Pubitemid 38998817)